Document Classification

Section Type: RESULTS

Text: After adjusting for age and stratifying by GOG performance status, stage, cell type, grade, debulking status and treatment regimen, high versus low CD105-MVD was associated with increased risk of disease progression (hazard ratio [HR] = 1. 873 ; 95 % confidence interval [CI] : 1. 102-3. 184 ; p = 0. 020), but not death (HR = 1. 125 ; 95 % CI : 0. 654-1. 935 ; p = 0. 670) whereas CD31-MVD was not associated with risk of disease progression (HR = 1. 578 ; 95 % CI = 0. 918-2. 711 ; p = 0. 099) or death (HR = 1. 678 ; 95 % CI = 0. 957-2. 943 ; p = 0. 071).